Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amino Acids for AKI Prevention in Infants After Cardiac Surgery
NCT07001098Phase 2Not yet recruiting
- Sponsor
- Stanford University
- Start
- Sep 2025
- Primary completion
- Nov 2026
- Modality
- Device-based Delivery, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of trophamine in acute kidney injury (AKI), sponsored by Stanford University. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
trophamine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07001098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07001098.